| CAS ID: | 185243-69-0 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Protein based biotech |
| Natural Product: | No |
| Other Names: | |
| Analysis: | N/A |
Reference Record 1
| PubMed ID | 16327802 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT00063869 | Disease | Pulmonary fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | July 9, 2003 | Last Verified | September 4, 2009 |
| Sponsor | Wyeth is now a wholly owned subsidiary of Pfizer | ||
| PubChem: | 10099 |
| ChEMBL: |